Advertisement

Sentinel Node Biopsy—Does It Help in the Management of Vulvar Cancer?

  • Maaike H. M. Oonk
  • Ate G. J. van der Zee
  • Paul Speiser
Chapter

Abstract

In the last decades, many modifications of surgery for vulvar cancer have been proposed in order to reduce the complication rate. The most recent modification is the introduction of the sentinel node procedure for patients with early stage vulvar cancer. The introduction of the sentinel node procedure brought about a major decrease in treatment-related morbidity. However, some controversies remain and these will be discussed in this chapter.

Keywords

Sentinel Node Sentinel Lymph Node Biopsy Vulvar Cancer Sentinel Node Procedure Negative Sentinel Lymph Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

Part I

  1. 1.
    Van der Zee AG, Oonk MH, de Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Hacker NF, Leuchter RS, Berek JS, et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574–9.PubMedGoogle Scholar
  4. 4.
    Burger MP, Hollema H, Emanuels AG, et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57:327–34.PubMedCrossRefGoogle Scholar
  5. 5.
    Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol. 2000;77:314–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicentre CTF study. Cancer. 2000;89:116–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Gonzalez-Bosquet J, Magrina JF, Gaffey TA, et al. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol. 2005;97:828–33.PubMedCrossRefGoogle Scholar
  8. 8.
    Rodolakis A, Diakomanolis E, Voulgaris Z, et al. Squamous vulvar cancer: a clinically based individualization of treatment. Gynecol Oncol. 2000;78:346–51.PubMedCrossRefGoogle Scholar
  9. 9.
    Berman ML, Soper JT, Creasman WT, et al. Conservative surgical management of superficially invasive stage I vulvar carcinoma. Gynecol Oncol. 1989;35:352–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol. 1992;79:490–7.PubMedGoogle Scholar
  11. 11.
    Burke TW, Levenback C, Coleman RL, et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995;57:215–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Gordinier ME, Malpica A, Burke TW, et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003;90:625–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Kirby TO, Rocconi RP, Numnum TM, et al. Outcomes of stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol. 2005;98:309–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Woolderink JM, de Bock GH, de Hullu JA, et al. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol. 2006;103:293–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Oonk MH, van de Nieuwenhof HP, van der Zee AG, de Hullu JA. Update on the sentinel lymph node procedure in vulvar cancer. Expert Rev Anticancer Ther. 2010;10:61–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Hampl M, Hantschmann P, Michels W, et al. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol. 2008;111:282–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Radziszewski J, Kowalewska M, Jedrzejczak T, et al. The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma. Gynecol Oncol. 2010;116:473–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30:3786–91.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Reade CJ, Jimenez W, O’Reilly D, Covens A. Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the Canadian health care context. J Obstet Gynaecol Can. 2012;34:1053–65.PubMedGoogle Scholar
  20. 20.
    Canlorbe G, Rouzier R, Bendifallah S, Chereau E. Impact of sentinel node technique on the survival in patients with vulvar cancer; analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Gynecol Obstet Fertil. 2012;40:647–51.PubMedCrossRefGoogle Scholar
  21. 21.
    Fons G, ter Rahe B, Sloof G, et al. Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node. Gynecol Oncol. 2004;92:981–4.PubMedCrossRefGoogle Scholar
  22. 22.
    De Hullu JA, Oonk MH, Ansink AC, et al. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol. 2004;94:10–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Levavi H, Sabah G, Hardoff R, et al. Failure of sentinel node identification following neo-adjuvant chemo-radiotherapy for locally advanced squamous cell carcinoma of the vulva. Eur J Gynaecol Oncol. 2003;24:433–4.PubMedGoogle Scholar
  24. 24.
    Oonk MH, van Os MA, de Bock GH, et al. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol. 2009;113:301–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Novackova M, Halaska MJ, Robova H, et al. A prospective study in detection of lower-limb lymphedema and evaluation of quality of life after vulvar cancer surgery. Int J Gynecol Cancer. 2012;22:1081–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279–93.PubMedCrossRefGoogle Scholar
  27. 27.
    Rietman JS, Geertzen JH, Hoekstra HJ, et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy. Eur J Surg Oncol. 2006;32:148–52.PubMedCrossRefGoogle Scholar

Part II

  1. 28.
    DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol. 1979;133:825.PubMedGoogle Scholar
  2. 29.
    Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol. 1992;79(4):490–7.PubMedGoogle Scholar
  3. 30.
    Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg. 2003;196:442.PubMedCrossRefGoogle Scholar
  4. 31.
    Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AA, Vergote I. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003;13:522.PubMedCrossRefGoogle Scholar
  5. 32.
    Podratz KC, Symmonds RE, Taylor WF, Williams TJ. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol. 1983;61:63.PubMedGoogle Scholar
  6. 33.
    Andersen BL, Hacker NF. Psychosexual adjustment after vulvar surgery. Obstet Gynecol. 1983;62:457.PubMedCentralPubMedGoogle Scholar
  7. 34.
    Barton DP. The prevention and management of treatment related morbidity in vulval cancer. Best Pract Res Clin Obstet Gynaecol. 2003;17:683.PubMedCrossRefGoogle Scholar
  8. 35.
    Tyring SK. Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment. Am J Obstet Gynecol. 2003;189:S17.PubMedCrossRefGoogle Scholar
  9. 36.
    Hacker NF, Van der Velden J. Conservative management of early vulvar cancer. Cancer. 1993;71:1673.PubMedCrossRefGoogle Scholar
  10. 37.
    De Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95:2331.PubMedCrossRefGoogle Scholar
  11. 38.
    Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev. 2000;(2):CD002036.Google Scholar
  12. 39.
    Helm CW, Hatch K, Austin JM, Partridge EE, Soong SJ, Elder JE, et al. A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva. Gynecol Oncol. 1992;46:150.PubMedCrossRefGoogle Scholar
  13. 40.
    Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58(5):574–9.PubMedGoogle Scholar
  14. 41.
    Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57(3):327–34.PubMedCrossRefGoogle Scholar
  15. 42.
    Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol. 2000;77(2):314–8.PubMedCrossRefGoogle Scholar
  16. 43.
    Rodolakis A, Diakomanolis E, Voulgaris Z, Akrivos T, Vlachos G, Michalas S. Squamous vulvar cancer: a clinically based individualization of treatment. Gynecol Oncol. 2000;78:346–51.PubMedCrossRefGoogle Scholar
  17. 44.
    Gonzalez Bosquet J, Magrina JF, Gaffey TA, Hernandez JL, Webb MJ, Cliby WA, et al. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol. 2005;97(3):828–33.PubMedCrossRefGoogle Scholar
  18. 45.
    Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113(4):895–901.PubMedGoogle Scholar
  19. 46.
    Robison K, Steinhoff MM, Granai CO, Brard L, Gajewski W, Moore RG. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: a comparison of the size of metastasis detected in inguinal lymph nodes. Gynecol Oncol. 2006;101:24.PubMedCrossRefGoogle Scholar
  20. 47.
    Mocellin S, Hoon DS, Pilati P, Rossi CR, Nitti D. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol. 2007;25:1588.PubMedCrossRefGoogle Scholar
  21. 48.
    Berman ML, Soper JT, Creasman WT, Olt GT, DiSaia PJ. Conservative surgical management of superficially invasive stage I vulvar carcinoma. Gynecol Oncol. 1989;35(3):352–7.PubMedCrossRefGoogle Scholar
  22. 49.
    Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995;57(2):215–20.PubMedCrossRefGoogle Scholar
  23. 50.
    Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003;90(3):625–8.PubMedCrossRefGoogle Scholar
  24. 51.
    Kirby TO, Rocconi RP, Numnum TM, Kendrick JE, Wright J, Fowler W, et al. Outcomes of stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol. 2005;98(2):309–12.PubMedCrossRefGoogle Scholar
  25. 52.
    Woolderink JM, de Bock GH, de Hullu JA, Davy MJ, van der Zee AG, Mourits MJ. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol. 2006;103(1):293–9.PubMedCrossRefGoogle Scholar
  26. 53.
    Courtney-Brooks M, Sukumvanich P, Beriwal S, Zorn KK, Richard SD, Krivak TC. Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease? Gynecol Oncol. 2010;17:308.CrossRefGoogle Scholar
  27. 54.
    Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26(6):884–9.PubMedCrossRefGoogle Scholar
  28. 55.
    Hampl M, Hantschmann P, Michels W, Hillemanns P, German Multicenter Study Group. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol. 2008;111(2):282–8.PubMedCrossRefGoogle Scholar
  29. 56.
    Radziszewski J, Kowalewska M, Jedrzejczak T, Kozlowicz-Gudzinska I, Nasierowska-Guttmejer A, Bidzinski M, et al. The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma. Gynecol Oncol. 2010;116(3):473–7.PubMedCrossRefGoogle Scholar
  30. 57.
    Oonk MH, van de Nieuwenhof HP, van der Zee AG, De Hullu JA. Update on the sentinel lymph node procedure in vulvar cancer. Expert Rev Anticancer Ther. 2010;10:61–9.PubMedCrossRefGoogle Scholar
  31. 58.
    Moore RG, Granai CO, Gajewski W, Gordinier M, Steinhoff MM. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol. 2003;91:378.PubMedCrossRefGoogle Scholar
  32. 59.
    Auger M, Colgan TJ. Detection of metastatic vulvar and cervical squamous carcinoma in regional lymph nodes by use of a polyclonal keratin antibody. Int J Gynecol Pathol. 1990;9:337.PubMedCrossRefGoogle Scholar
  33. 60.
    Hakam A, Nasir A, Raghuwanshi R, Smith PV, Crawley S, Kaiser HE, et al. Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva. Anticancer Res. 2004;24:1281.PubMedGoogle Scholar
  34. 61.
    Regauer S. Histopathological work-up and interpretation of sentinel lymph nodes removed for vulvar squamous cell carcinoma. Histopathology. 2009;55:174–81.PubMedCrossRefGoogle Scholar
  35. 62.
    Cox CE, Dupont E, Whitehead GF, Ebert MD, Nguyen K, Peltz ES, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 2002;8:88–91.PubMedCrossRefGoogle Scholar
  36. 63.
    De Hullu JA, Oonk MH, Ansink AC, Hollema H, Jager PL, van der Zee AG. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol. 2004;94(1):10–5.PubMedCrossRefGoogle Scholar
  37. 64.
    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2011;61(2):133–4.CrossRefGoogle Scholar
  38. 65.
    Cox CE, Haddad F, Bass S, Cox JM, Ku NN, Berman C, et al. Lymphatic mapping in the treatment of breast cancer. Oncology. 1998;12:1283.PubMedGoogle Scholar
  39. 66.
    Morton DL. Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation? Cancer J Sci Am. 1997;3:328.PubMedGoogle Scholar
  40. 67.
    Euhus DM, Peters GN, Leitch AM, Saboorian H, Mathews D, Erdman W, et al. Validating the performance of the mammary sentinel lymph node team. J Surg Oncol. 2002;79:209.PubMedCrossRefGoogle Scholar
  41. 68.
    Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, et al. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg. 2005;241(1):48.PubMedCentralPubMedGoogle Scholar
  42. 69.
    Levenback CF, van der Zee AG, Rob L, Plante M, Covens A, Schneider A, et al. Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol. 2009;114(2):151–6.PubMedCrossRefGoogle Scholar
  43. 70.
    De Hullu JA, Ansink AC, Tymstra T, van der Zee AG. What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancer. J Psychosom Obstet Gynaecol. 2001;22(4):199–203.PubMedCrossRefGoogle Scholar
  44. 71.
    Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat. 1996;38:183–99.PubMedCrossRefGoogle Scholar
  45. 72.
    Sprangers MA. Quality-of-life assessment in oncology. Acta Oncol. 2002;41:229–37.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  • Maaike H. M. Oonk
    • 1
  • Ate G. J. van der Zee
    • 1
  • Paul Speiser
    • 2
  1. 1.Obstetrics and GynaecologyUniversity Medical Center GroningenGroningenThe Netherlands
  2. 2.Gynaecologic OncologyMedical University, ViennaViennaAustria

Personalised recommendations